Law Firm Press Releases

Auto Added by WPeMatico

VA Examining Possible Link Between Agent Orange, Brain Cancer in Light of Senator John McCain’s Recent Diagnosis

Tampa, FL (Law Firm Newswire) September 15, 2017 – The recent revelation by Sen. John McCain, R-Ariz., that he was diagnosed with glioblastoma multiforme, an aggressive form of brain cancer that is fatal, has caused some individuals to ask the VA to conduct a study of the potential link between exposure to Agent Orange and the illness. The U.S. Department of Veterans Affairs (VA) has come under additional pressure to expand eligibility requirements for compensation.

Tampa, Florida veterans lawyer, David W. Magann, states “Pending the outcome of the new study that is under way concerning the link between glioblastoma and Agent Orange, it remains to be seen whether brain cancer patients who were exposed to the herbicide will be eligible for veterans’ benefits.”

According to current law, the VA provides disability benefits to veterans who develop one of several ailments, but only if they can show they served on the grounds in Vietnam. Veterans who served in the Navy off the coast and those who developed other illnesses, including brain cancer, must apply to the VA for compensation on an individual basis.

McCain endured more than five years in a prison camp after his plane was shot down in North Vietnam. The VA would have assumed he suffered exposure to the herbicide because he served on the ground in Saigon. Nevertheless, McCain never tried to associate any of his health conditions with such exposure, and has been inconsistent in trying to obtain compensation for veterans for exposure during the war.

A representative from the VA said that in light of the questions that have arisen surrounding the possible link between Agent Orange and brain cancer, the agency is again conducting an examination of the subject. Additionally, the VA has requested that a panel of the National Academy of Medicine direct special attention to glioblastoma. Moreover, the VA is currently raising questions pertaining to brain cancer in a survey of Vietnam veterans.

David W. Magann, P.A.
Main Office:
156 W. Robertson St.
Brandon, FL 33511
Call: (813) 657-9175

Tampa Office:
4012 Gunn Highway #165
Tampa, Florida 33618


View Larger Map

See other news sources publishing this article. BETA |

New Zealand Law Society to introduce charter to better advance women in law

Lawyers are encouraged to comment on a draft Gender Diversity and Inclusion Charter being developed for the legal profession.

The charter is an initiative of the Law Society’s Women’s Advisory Panel that was set up to look at ways to support the retention and advancement of women in the legal profession.

“Gender diversity is critical to the success and sustainability of the legal profession. I hope the charter will help accelerate the progress of women to leadership positions in law,” says chair of the Women’s Advisory Panel, Chris Moore.

In recent years women have made up close to 70% of law graduates from universities, and almost 50% of those holding practising certificates. Yet women make up less than 30% of those who are partners or directors in law firms.

“We need to see greater progress in terms of the advancement of women to the higher ranks of the legal profession. The charter is about the profession committing to concerted action to address this visible and longstanding problem,” says New Zealand Law Society President, Kathryn Beck.

The Gender Diversity and Inclusion Charter is voluntary but requires law firms and in-house teams that sign up to the charter to make a number of commitments.

Some of the key commitments as a signatory include:  

  • Implement unconscious bias training for all lawyers and key staff.
  • Develop recruitment, retention and promotion policies that include diversity and inclusion as an important consideration.
  • Conduct annual gender pay audits to identify and eliminate unjustifiable pay disparities based on gender.
  • Encourage and support flexible working to assist all lawyers to balance professional and personal responsibilities.
  • Actively work to increase the percentage of women in senior legal roles.
  • Assign responsibility for meeting charter commitments to a named, senior level individual within the law firm.
  • Collect and share with the New Zealand Law Society examples of practical approaches to diversity and inclusion that make a real difference.
  • Measure and report on progress against charter commitments every two years to the New Zealand Law Society.

“The culture across the legal profession needs to move forward if we are to retain our many women practitioners. We believe these are the right areas to target in addressing this vital issue,” Ms Beck says.

The New Zealand Law Society is seeking feedback from all lawyers on the draft charter by 6 October. To provide feedback click here or email womeninlaw@lawsociety.org.nz

The Law Society’s Gender Diversity and Inclusion Charter is part of a broader programme of work on diversity. The charter will evolve over time to also include other aspects of diversity such as ethnic and cultural diversity.

If you have further questions please contact Fazleen Ismail, General Manager, Law Reform and Sections by emailing womeninlaw@lawsociety.org.nz

VA Fires Head of DC Facility Amid Confidentiality Breach, Leadership Concerns Says Veterans Attorney Jim Fausone

Legal Help for Veterans is a law firm helping veterans get the benefits they deserve.

Northville, MI (Law Firm Newswire) September 14, 2017 – The Department of Veterans Affairs (VA) fired the longtime director of its main veterans medical center in Washington, D.C.

Brian Hawkins was dismissed due to growing concerns about his leadership of the VA facility. The VA released a statement saying “he failed to provide effective leadership.” Hawkins was reassigned to a different post within the agency in April pending further review. Retired Army Col. Lawrence Connell has served as the hospital’s acting director since then.

“The disciplinary action taken against Brian Hawkins reiterates the fact that the VA is now more committed to enhancing accountability in the department,” commented Jim Fausone, a Michigan veterans attorney. “Both VA employees and leaders should face the appropriate consequences if they put veterans at the risk of harm and are not aligned with the VA’s mission.”

Hawkins’ departure followed several months of investigations by the VA Office of Inspector General. Audits found evidence of mismanagement at the facility. The hospital’s patients were endangered by poor inventory practices and organizational dysfunction.

The VA Inspector General Michael J. Missal released the findings of an internal probe in April. His report documented “the highest levels of chaos” at the Washington, D.C. medical center, including large-scale medical supply shortages and unsanitary conditions in equipment storage areas.

The VA had an even bigger cause for concern when its internal watchdog made public another report in June. It revealed that Hawkins had emailed “sensitive” information about administrative decisions and VA staff to his wife’s personal account. She is not a VA employee. According to the report, the emails were a breach of the department’s rules on data confidentiality.

Hawkins was fired after the inspector general’s office recommended new disciplinary action be taken against him. Missal was unable to prove separate accusations of Hawkins trying to obstruct an investigation into staff bonuses that he authorized “without proper justification.” The report, however, said his employees delayed providing certain documents related to the probe.

Legal Help for Veterans, PLLC
41700 West Six Mile Road, Suite 101
Northville, MI 48168
Toll Free Phone: 800.693.4800

See other news sources publishing this article. BETA |

RapidFunds® Launches Innovative Financing Option for Law Firms

New product offers contingency fee firms unprecedented flexibility in managing their cash flow

WHITE PLAINS, NEW YORK, UNITED STATES , September 13, 2017 /EINPresswire.com/ — New York, NY, September –, 2017 – RapidFunds® announced today a game-changing financing vehicle for the legal industry. The company will offer a rolling line of credit to law firms allowing them to draw on a traditional line of credit while also taking advantage of post-settlement funding to successfully run their practice. This is a new product in the industry aimed at helping contingent fee attorneys who face unique challenges because of irregular cash flow and limited funding options available in the market.
“We have always sought to be innovators in legal funding,” says Charles Brofman, co-Founder of RapidFunds®. “We were among the first to offer post-settlement funding to law firms and now we continue that tradition with launch of our rolling line of credit option.” The new financing vehicle provides significant benefits over traditional lending. Once a firm draws down its line of credit, traditional lenders require that the firm use 30-40% of their legal fees to pay down the line of credit and prohibits the firm from drawing on that money for 3 to 6 months. If the firm needs to pay expenses in the meantime, it has few options because it won’t be able to obtain post-settlement funding due to the bank’s lien for the line of credit.
RapidFunds® new product solves this problem. It provides law firms with both a line of credit and access to post-settlement funding of a case when needed to meet the firm’s cash flow needs. If firms have used their line of credit, but still need more cash, they can roll over funds from their line of credit to their post-settlement funding and receive additional capital on their post settlement funding request, in order to further maximize their settled cases. “Our goal is to give law firms the flexibility they need in their business so they can continue to do what they do best – practice law,” explains Mr. Brofman. “Our firm was founded by litigators. We understand their challenges and want to be their partner in helping them succeed.”
To learn more about RapidFunds® new Rolling Line of Credit, contact Charles Brofman at 914 368 7249 ext 5605.

About RapidFunds®
RapidFunds® was founded in 2004 by attorneys Charles S. Brofman, Esq. and Peter J. Speziale, Esq., as a solution to the cash flow problems contingent fee attorneys face because of frequent delays in receiving settlement proceeds. A pioneer in the legal funding industry, the company has successfully expedited over 3,000 legal fee acceleration transactions nationwide.

Charles Brofman
Rapid Funds
914 368 7249 ext 5605
email us here

SEQUANS NOTICE: Rosen Law Firm Reminds Sequans Communications S.A. Investors of Important Deadline in First Filed Class Action – SQNS

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Sequans Communications S.A. (NYSE:SQNS) from April 29, 2016 through July 31, 2017, inclusive (the “Class Period”) of the important October 10, 2017 lead plaintiff deadline in the first filed class action commenced by Rosen Law Firm. The lawsuit seeks to recover damages for Sequans investors under the federal securities laws.

To join the Sequans class action, go to http://www.rosenlegal.com/cases-1178.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Sequans was improperly recognizing revenue; and (2) as a result, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 10, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1178.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising.  Prior results do not guarantee a similar outcome.

Contact Information:
      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com

/EIN News/ —

IPCI ALERT: Rosen Law Firm Reminds Intellipharmaceutics International Inc. Investors of Important Deadline in Class Action – IPCI

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Intellipharmaceutics International Inc. (NASDAQ: IPCI) from January 14, 2016 through July 26, 2017, inclusive (the “Class Period”) of the important September 29, 2017 lead plaintiff deadline. The lawsuit seeks to recover damages for Intellipharmaceutics investors under the federal securities laws.

To join the Intellipharmaceutics class action, go to http://rosenlegal.com/cases-1172.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Intellipharmaceutics failed to conduct a human abuse liability study to support its Rexista New Drug Application (“NDA”); (2) the Company did not include abuse-deterrent studies conducted to suppose abuse-deterrent label claims related to abuse of the drug by various pathways; (3) the Company was not submitting sufficient data to support approval of the NDA; and (4) as a result, Defendants’ statements about Intellipharmaceutics’ business, operations, and prospects were false and misleading and/or lacked a reasonable basis. On July 27, 2017, shares of Intellipharmaceutics fell when the FDA released a report disclosing that “The safety information collected in the pharmacokinetic studies was of limited value…” When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 29, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1172.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising.  Prior results do not guarantee a similar outcome.

Contact Information:
      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com

/EIN News/ —

FRTA ALERT: Rosen Law Firm Reminds Forterra, Inc. Investors of Important Deadline in Class Action – FRTA

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of Forterra, Inc. securities (NASDAQ:FRTA) pursuant to and/or traceable to the Registration Statement and Prospectus issued in connection with Forterra’s October 21, 2016 initial public offering (the “Offering”) of the important October 13, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Forterra investors under the federal securities laws.

To join the Forterra class action, go to the firm’s website at http://rosenlegal.com/cases-1195.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

The complaint alleges that the Registration Statement used to conduct the IPO contained inaccurate statements and omitted facts necessary to make other statements made therein not misleading. Among other things, the Registration Statement failed to disclose, at the time of the IPO, that organic sales in Forterra’s Drainage and Water segments had significantly declined, that Forterra was experiencing increased pricing pressure due to competition and continued softness in its concrete and steel pipe business, that Forterra had been losing business in its important pipe and precast business due to in large part to operational problems at its production plants, and that Forterra had undisclosed material weaknesses in its internal controls that prevented it from accurately reporting and forecasting its financial results. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 13, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1195.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising.  Prior results do not guarantee a similar outcome.

Contact Information:
      Laurence Rosen, Esq.
      Phillip Kim, Esq.
      Kevin Chan, Esq.
      The Rosen Law Firm, P.A.
      275 Madison Avenue, 34th Floor
      New York, NY  10016
      Tel: (212) 686-1060
      Toll Free: (866) 767-3653
      Fax: (212) 202-3827
      lrosen@rosenlegal.com
      pkim@rosenlegal.com
      kchan@rosenlegal.com
      www.rosenlegal.com

/EIN News/ —

TABLEAU ALERT: Rosen Law Firm Reminds Tableau Software, Inc. Investors of Important Class Action Deadline – DATA

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Tableau Software, Inc. (NYSE:DATA) from June 3, 2015 through February 4, 2016, inclusive (the “Class Period”) of the important September 26, 2017 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Tableau investors under the federal securities laws.

To join the Tableau class action, go to http://rosenlegal.com/cases-1177.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) product launches and upgrades by major software competitors were negatively impacting Tableau’s competitive position and profitability; and (2) as a result of the foregoing, Tableau’s financial statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 26, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1177.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising.  Prior results do not guarantee a similar outcome.

Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY  10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

/EIN News/ —

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Electronics For Imaging, Inc. – EFII

NEW YORK, Sept. 13, 2017 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Electronics For Imaging, Inc. (NASDAQ:EFII) from February 22, 2017 through August 3, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Electronics For Imaging investors under the federal securities laws.

To join the Electronics For Imaging class action, go to http://www.rosenlegal.com/cases-1181.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Electronics For Imaging was improperly recognizing revenue; (2) Electronics For Imaging’s disclosure controls and procedures were not effective; (3) Electronics For Imaging’s internal control over financial reporting were not effective; and (4) as a result, Electronics For Imaging’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 10, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1181.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors.

/EIN News/ — Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 34th Floor
New York, NY  10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
kchan@rosenlegal.com
www.rosenlegal.com

Research Shows That Players in Sports Other Than Football, Also Suffer From Traumatic Brain Injuries

Austin Personal Injury Lawyers

Austin Personal Injury Lawyers – Perlmutter & Schuelke, PLLC

Austin, TX (Law Firm Newswire) September 13, 2017 – The prevalence of traumatic brain injuries in players in contact sports is now well known. In fact, the initial discovery of chronic traumatic encephalopathy (CTE) was in the brains of deceased football players.

A new study published by Boston University (BU) scientists revealed that 110 out of 111 post-mortem brains showed signs of CTE. Brain damage allegations have been trailing the National Football League (NFL) for over a decade. Chronic traumatic encephalopathy in football players has seen congressional hearings, been the cited reason for a class action lawsuit launched by players and the hopeful beneficiary of efforts to design new helmets and ban certain kinds of hits.

Chronic traumatic encephalopathy, a degenerative brain disease linked to repetitive head trauma, was first revealed in football players. Since the initial discovery of the disease and what it does to the brain scientists have discovered that linebackers, who engage in a series of smaller collisions during every play, do worse than other players who may take harder, but fewer hits during the average game. But football is not the only contact sport where repeated head trauma is common.

Neurologists are stating the trauma sustained by soccer players may rival football’s impact on the brain. It does not matter how head contact/impact comes about, but that it is done repeatedly.

While soccer, with 265 million players globally, is not traditionally considered a contact sport, the way the game is played does result in concussions due to heading the ball, player-to-player head bunting contact, and falls. In recreational games, soccer players head the ball roughly six to 12 times a game, deflecting balls traveling up to 50 mph. While practicing, players head the ball up to 30 or more times repeatedly while performing drills.

In the past 10 years, DC United, a U.S. pro soccer team lost six players due to concussions. This season at least two of their players missed field time with head trauma. Furthermore, case studies show retired Brazilian and English players with a history of concussions while playing later showed signs of dementia with subsequent autopsies revealing CTE.

Certainly all of the traumatic brain injury issues in soccer are beginning to become more visible thanks to lawsuits and the settlement of a potential class action lawsuit. Charlie Horton, a former DC United goalkeeper, stated in his lawsuit that a teammate deliberately elbowed him in the head resulting in concussion and the end of his career. In 2015 the U.S. Soccer Federation settled a potential class action lawsuit by limiting “heading” by youth players.

“The legal issue usually involved in many lawsuits of this nature is whether or not the team management/owners gave players sufficient warning to make informed choices about running the risk of head injuries,” explained Brooks Schuelke, an Austin traumatic brain injury attorney. “If you are in a situation where you feel you were not properly advised about the dangers of playing contact sports, seek legal counsel to find out your rights and how to file a lawsuit if you wish to proceed in that manner.”

Perlmutter & Schuelke, PLLC
206 East 9th Street, Ste. 1511
Austin, TX 78701
Call (512) 476-4944


View Larger Map

See other news sources publishing this article. BETA |